Docebo Inc. Common Shares (DCBO)
Docebo Inc. is a cloud-based learning management system (LMS) provider that offers a platform for corporate training and e-learning. Established to help organizations deliver, manage, and track online training programs, Docebo's solutions are used globally across various industries to enhance employee development, onboarding, and compliance training. The company's technology emphasizes user engagement, customization, and integration with other enterprise systems.
Company News
Brandon Hall Group, a leading HCM research and analyst firm, has announced the winners of the 2024 Excellence in Technology Awards, recognizing organizations that have successfully deployed innovative and impactful technology solutions in various areas of human capital management.
The article discusses two companies, UiPath and Docebo, that have compelling growth prospects and reasonable valuations. UiPath is the leader in robotic process automation, while Docebo specializes in corporate learning software. Both companies are well-positioned to benefit from the growth of their respective markets and the potential of generative AI.
Investors need to pay close attention to Docebo (DCBO) stock based on the movements in the options market lately
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Jefferies cut the price target for Applied Materials, Inc. (NASDAQ:AMAT) from $215 to $210. Jefferies analyst Blayne Curtis downgraded the stock from Buy to Hold. Applied Materials shares rose 1.7% to close at $209.73 on Friday. See how other analysts view this stock. Baird boosted the price target for Mettler-Toledo International Inc. (NYSE:MTD) from $1,212 to $1,360. Baird analyst Catherine Schulte maintained a Neutral rating. Mettler-Toledo International shares jumped 17% to close at $1,510.25 on Friday. See how other analysts view this stock. HC Wainwright & Co. cut Biohaven Ltd. (NYSE:BHVN) price target from $63 to $59. HC Wainwright & Co. analyst Douglas Tsao maintained a Buy rating. ...Full story available on Benzinga.com